Evans M - Search Results

1

Lead-time bias in studies of cinacalcet prescriptions.

Evans M, Fored CM. Evans M, et al. Kidney Int. 2010 Sep;78(6):535-7. doi: 10.1038/ki.2010.220. Kidney Int. 2010. PMID: 20805815 Free article.

2

The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.

Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyrén O, Fored CM. Evans M, et al. Am J Kidney Dis. 2005 Nov;46(5):863-70. doi: 10.1053/j.ajkd.2005.07.040. Am J Kidney Dis. 2005. PMID: 16253726

3

Acetaminophen, aspirin and progression of advanced chronic kidney disease.

Evans M, Fored CM, Bellocco R, Fitzmaurice G, Fryzek JP, McLaughlin JK, Nyrén O, Elinder CG. Evans M, et al. Nephrol Dial Transplant. 2009 Jun;24(6):1908-18. doi: 10.1093/ndt/gfn745. Epub 2009 Jan 20. Nephrol Dial Transplant. 2009. PMID: 19155536

4

Occupational lead exposure and severe CKD: a population-based case-control and prospective observational cohort study in Sweden.

Evans M, Fored CM, Nise G, Bellocco R, Nyrén O, Elinder CG. Evans M, et al. Am J Kidney Dis. 2010 Mar;55(3):497-506. doi: 10.1053/j.ajkd.2009.11.012. Epub 2010 Feb 8. Am J Kidney Dis. 2010. PMID: 20116912

5

No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease.

Evans M, Tettamanti G, Nyrén O, Bellocco R, Fored CM, Elinder CG. Evans M, et al. J Intern Med. 2011 Mar;269(3):289-98. doi: 10.1111/j.1365-2796.2010.02280.x. Epub 2010 Sep 10. J Intern Med. 2011. PMID: 20831629 Free article.

6

Chronic renal failure from lead: myth or evidence-based fact?

Evans M, Elinder CG. Evans M, et al. Kidney Int. 2011 Feb;79(3):272-9. doi: 10.1038/ki.2010.394. Epub 2010 Oct 13. Kidney Int. 2011. PMID: 20944550 Free article. Review.

7

Chronic renal failure induced by lead.

Evans M, Elinder CG. Evans M, et al. Kidney Int. 2011 Mar;79(6):688-689. doi: 10.1038/ki.2010.508. Kidney Int. 2011. PMID: 21358661 Free article. No abstract available.

8

Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease.

Carrero JJ, Varenhorst C, Jensevik K, Szummer K, Lagerqvist B, Evans M, Spaak J, Held C, James S, Jernberg T. Carrero JJ, et al. Among authors: evans m. Kidney Int. 2017 Jan;91(1):216-226. doi: 10.1016/j.kint.2016.09.014. Epub 2016 Nov 16. Kidney Int. 2017. PMID: 27865441 Free article.

9

Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.

Carrero JJ, Grams ME, Sang Y, Ärnlöv J, Gasparini A, Matsushita K, Qureshi AR, Evans M, Barany P, Lindholm B, Ballew SH, Levey AS, Gansevoort RT, Elinder CG, Coresh J. Carrero JJ, et al. Among authors: evans m. Kidney Int. 2017 Jan;91(1):244-251. doi: 10.1016/j.kint.2016.09.037. Epub 2016 Dec 4. Kidney Int. 2017. PMID: 27927597 Free PMC article.

10

Outcomes associated to serum phosphate levels in patients with suspected acute coronary syndrome.

Xu H, Evans M, Gasparini A, Szummer K, Spaak J, Ärnlöv J, Lindholm B, Jernberg T, Carrero JJ. Xu H, et al. Among authors: evans m. Int J Cardiol. 2017 Oct 15;245:20-26. doi: 10.1016/j.ijcard.2017.07.050. Epub 2017 Jul 17. Int J Cardiol. 2017. PMID: 28734575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,105 results

Search Page